Browsing Tag
Dr. Reddy’s Laboratories Limited
3 posts
Who is really leading Indian pharma in 2026? The top 10 companies explained beyond the hype
Discover the top 10 pharma companies in India in 2026, who leads by revenue, reach, and strategy, and why the ranking is more complex than it looks.
Dr. Reddy’s (NSE: DRREDDY) acquires Progynova and Cyclo-Progynova to enter India’s hormone replacement therapy market
Dr. Reddy’s Laboratories Limited enters hormone replacement therapy with a $32 million India acquisition. Find out why this move matters now.
Biologics race in Indian pharma: Can Glenmark’s AbbVie tie-up spark a broader innovation moment?
India’s biologics race heats up as Glenmark, Biocon, Sun Pharma, Dr. Reddy’s, and Lupin push beyond generics—see how each strategy stacks up.